Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

MLAB vs ARAI: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

MLAB Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 9–1 Matrix Metrics)

MLAB Overall Winner 6-Pillar Tally: MLAB 5 – 1 ARAI Matrix Metrics: MLAB 9 – 1 ARAI

As of Nov 20, 2026, Mesa Laboratories Inc (MLAB) is the stronger overall head-to-head candidate over Arrive AI Inc. (ARAI) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). MLAB carries a Unified Composite Score of 55.4/100 (HOLD) at $127.93 (23.7x Forward P/E, 10.4% operating margin), whereas ARAI carries 34.4/100 (SELL) at $1.21 (N/M Forward P/E, -18105.8% operating margin).

  • Growth vs. Quality Trade-Off: MLAB earns the overall head-to-head edge with a stronger Unified Composite Score (55.4/100 HOLD vs. ARAI 34.4/100 SELL) and 1.13β · 55% Vol risk profile, whereas ARAI leads top-line expansion (+432.9% YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About MLAB vs ARAI
MLAB NASDAQ Head-to-Head Winner
Mesa Laboratories Inc
Industrial Instruments For Measurement, Display, And Control
$127.93
-4.11% 1D
Market Cap $749.8M
TTM Revenue $251M
Forward P/E 23.7x
Beta / 30D Vol 1.13β · 55% Vol
Unified Composite Score
55.4 / 100 HOLD
Tech 48.0 Fund 49.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 47
RSI-14: 46.8 · SMA20: $130.92 · SMA50: $130.04
ARAI NASDAQ
Arrive AI Inc. Common Stock
Services-To Dwellings & Other Buildings
$1.21
-21.94% 1D
Market Cap $2.2M
TTM Revenue $84,400
Forward P/E N/M
Beta / 30D Vol -4.44β · 11485% Vol
Unified Composite Score
34.4 / 100 SELL
Tech 50.0 Fund 32.0 Flow 50.0 Mom 58.9
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (91.3% over 20 days), RSI 58
RSI-14: 58.1 · SMA20: $0.72 · SMA50: $0.40

6-Pillar Scorecard Institutional Category Breakdown (MLAB 5 – 1 ARAI)

Columns: Metric · MLAB · ARAI
1. Valuation Multiples MLAB
Forward P/E 23.7x N/M
Trailing P/E 115.0x N/M
PEG Ratio N/M N/M
EV / Revenue 3.0x 55.5x
2. Growth & Scale MLAB
Revenue Growth (YoY) +2.6% +432.9%
Earnings Growth (YoY) +67.0% +0.0%
TTM Revenue (USD) $251M $84,400
Market Cap $749.8M $2.2M
3. Profitability & Quality MLAB
Gross Margin 64.8% 100.0%
Operating Margin 10.4% -18105.8%
Net Profit Margin 2.6% 0.0%
Return on Equity (ROE) 3.6% -840.7%
4. Balance Sheet & Cash Flow MLAB
Cash Generation (TTM) $49M EBITDA -$15M EBITDA
Cash Flow Margin 19.4% EBITDA Mgn N/A
Net Cash / Leverage $34.66 Book/Sh · 3.6% ROE $2.5M Net Debt (1.15x D/E)
Dividend Yield 0.46% None (0.00%)
5. Options & Positioning ARAI
Options Structure Phase UNCLASSIFIED SURGE
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral ACCUMULATION · Markup
6. R&D & Supply-Chain Moat MLAB
OpEx & R&D Intensity 54.4% of Rev ($137M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Scientific & Technical Instruments Operator Scientific & Technical Instruments Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: MLAB (9) vs ARAI (1)
Institutional Metric MLAB ARAI Criterion Row Edge
Market Capitalization
Scale
$749.8M $2.2M Larger Scale MLAB
Trailing P/E Ratio
Valuation
115.0x N/M Lower Multiple MLAB
Forward P/E Ratio
Valuation
23.7x N/M Lower Multiple MLAB
Revenue Growth (YoY)
Growth
+2.6% +432.9% Higher Growth ARAI
Operating Margin (TTM)
Profitability
10.4% -18105.8% Higher Margin MLAB
Net Profit Margin
Profitability
2.6% 0.0% Higher Margin MLAB
Return on Equity (ROE)
Capital Efficiency
3.6% -840.7% Higher ROE MLAB
52-Week Range Position
Momentum
78% ($70–$144) 28% ($0–$4) Stronger Trend MLAB
Beta / 30D Volatility
Risk Regime
1.13β · 55% Vol -4.44β · 11485% Vol Lower Realized Risk MLAB
Unified Institutional Score
Composite Signal
55.4 / 100 (HOLD) 34.4 / 100 (SELL) Higher Composite MLAB
Trailing 12M Revenue (USD)
Operating Scale
$251M $84,400 FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
64.8% 100.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 3.0x EV/Rev N/M PEG · 55.5x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$49M EBITDA ($34.66 Book/Sh · 3.6% ROE) -$15M EBITDA ($2.5M Net Debt (1.15x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ARAI +855.17 pp
MLAB: -0.91% · ARAI: +854.26%
3M Horizon ARAI +420.68 pp
MLAB: +2.9% · ARAI: +423.58%
6M Horizon ARAI +70.95 pp
MLAB: +17.76% · ARAI: +88.71%
1Y Horizon MLAB +147.75 pp
MLAB: +80.9% · ARAI: -66.85%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MLAB vs ARAI. Trailing 12-month operating profitability (MLAB 10.4% vs ARAI -18105.8%) and valuation multiples (MLAB 23.7x vs ARAI N/M Forward P/E) are benchmarked directly in Pillar 4 below.

MLAB ADR TTM Benchmark FX-Normalized USD
TTM Revenue$251M
Gross Margin64.8%
Op. Margin10.4%
ROE / Fwd P/E3.6% · 23.7x
ARAI ADR TTM Benchmark FX-Normalized USD
TTM Revenue$84,400
Gross Margin100.0%
Op. Margin-18105.8%
ROE / Fwd P/E-840.7% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
MLAB UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact MLAB Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ARAI SURGE
5d in phase · OBV ACCUMULATION
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow ACCUMULATION
Exact ARAI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
MLAB Moat Profile Cyclical / Execution-Driven Positioning
Scientific & Technical Instruments Operator
Competes within the Scientific & Technical Instruments value chain with $749.8M market capitalization and 10.4% operating margin.
OpEx & R&D Reinvestment 54.4% of Rev ($137M)
90D Engineering Disclosures 0 Published
ARAI Moat Profile Cyclical / Execution-Driven Positioning
Scientific & Technical Instruments Operator
Competes within the Scientific & Technical Instruments value chain with $2.2M market capitalization and -18105.8% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ MLAB vs ARAI Key Questions & Quantitative Answers

As of Nov 20, 2026, Mesa Laboratories Inc (MLAB) is the stronger overall head-to-head candidate over Arrive AI Inc. (ARAI) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). MLAB carries a Unified Composite Score of 55.4/100 (HOLD) at $127.93 (23.7x Forward P/E, 10.4% operating margin), whereas ARAI carries 34.4/100 (SELL) at $1.21 (N/M Forward P/E, -18105.8% operating margin). Growth vs. Quality Trade-Off: MLAB earns the overall head-to-head edge with a stronger Unified Composite Score (55.4/100 HOLD vs. ARAI 34.4/100 SELL) and 1.13β · 55% Vol risk profile, whereas ARAI leads top-line expansion (+432.9% YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates.

MLAB leads the Growth & Scale pillar: MLAB posts +2.6% YoY revenue growth and +67.0% YoY earnings growth on $251M TTM revenue (64.8% gross margin, 10.4% operating margin), compared with ARAI at +432.9% YoY revenue growth and +0.0% YoY earnings growth on $84,400 TTM revenue (100.0% gross margin, -18105.8% operating margin). On trailing 12-month operating scale, MLAB generates $251M in USD-normalized revenue versus $84,400 for ARAI. In operating R&D and SG&A reinvestment, MLAB deploys 54.4% of Rev ($137M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ARAI.

MLAB screens cheaper on headline valuation multiples. MLAB trades at 23.7x Forward P/E, 115.0x Trailing P/E, N/M PEG, and 3.0x EV/Revenue (19.4% EBITDA margin), whereas ARAI trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 55.5x EV/Revenue (unreported EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MLAB (3.6% ROE) versus ARAI (-840.7% ROE) capital efficiency.

In options market volatility and institutional positioning, MLAB carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.13β · 55% Vol realized risk). By comparison, ARAI carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a SURGE options structure phase (-4.44β · 11485% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.